首页|丁苯酞联合替格瑞洛对缺血性脑血管病患者的疗效

丁苯酞联合替格瑞洛对缺血性脑血管病患者的疗效

扫码查看
目的 探讨丁苯酞联合替格瑞洛对缺血性脑血管病(ICD)患者的疗效及对心理状态、认知功能的影响.方法 选取2020年1月至2022年1月新乡市中心医院收治的120例ICD患者为研究对象,并通过随机数字表法分为对照组(60例)、联合组(60例).所有患者均接受常规治疗,对照组接受替格瑞洛治疗,联合组接受替格瑞洛联合丁苯酞治疗.治疗2周,对比两组疗效、心理状态、神经功能、认知功能、血清学指标[降钙素基因相关肽(CGRP)、同型半胱氨酸(Hcy)]及药物不良反应(ADR)情况.结果 联合组总有效率为93.33%,较对照组的80.00%高(P<0.05);两组治疗2周后汉密尔顿焦虑量表(HAMA)、汉密尔顿抑郁量表(HAMD)评分、神经功能缺损(NDF)量表评分及血清Hcy水平均较治疗前低(P<0.05),联合组低于对照组(P<0.05);两组治疗2周后蒙特利尔认知功能评定表(MoCA)评分及血清CGRP水平均较治疗前高(P<0.05),联合组高于对照组(P<0.05);联合组、对照组ADR分别为8.33%、5.00%,组间比较差异无统计学意义(P>0.05).结论 对ICD患者应用丁苯酞联合替格瑞洛治疗,疗效较佳,可调节血清CGRP、Hcy水平,改善神经功能、认知功能,减轻负面心理,且ADR较少.
Efficacy of Butylphthalide Combined with Ticagrelor in Patients with Ischemic Cerebrovascular Disease
Objective To investigate the efficacy of butylphthalide combined with ticagrelor on ischemic cerebrovascular disease(ICD)patients and its influences on psychological state and cognitive function.Methods From January 2020 to January 2022,120 ICD patients admitted to Xinxiang Central Hospital were taken as the research subjects,and grouped into control group(60 cases)and combined group(60 cases)by random number table method.All patients received routine treatment,the control group was treated with ticagrelor,and the combined group was treated with ticagrelor combined with butylphthalide.After 2 weeks of treatment,the curative effect,psychological state,neurological function,cognitive function,serological indexes[calcitonin gene-related peptide(CGRP),homocysteine(Hcy)]and adverse drug reactions(ADR)were compared between the two groups.Results The total effective rate of the combined group was 93.33%,which was higher than that of the ticagrelor group(80.00%)(P<0.05).After 2 weeks of treatment,the scores of Hamilton anxiety scale(HAMA),Hamilton depression scale(HAMD),neurological deficit(NDF)scale,and serum Hcy level in the two groups were lower than those before treatment(P<0.05),and those in the combined group were lower than those in the control group(P<0.05);after 2 weeks of treatment,the Montreal Cognitive Assessment(MoCA)score and serum CGRP level in the two groups were higher than those before treatment(P<0.05),and the combined group were higher than the control group(P<0.05).The ADRs in the combined group and control groupwere 8.33%and 5.00%,respectively,and there was no difference between the groups(P<0.05).Conclusion Butylphthalide combined with ticagrelor for ICD patients has better curative effect,and it can regulate serum CGRP and Hcy levels,improve neurological and cognitive functions,reduce negative psychology,and has less ADR.

butylphthalideticagrelorischemic cerebrovascular diseasemental statecognitive function

畅慧君

展开 >

新乡市中心医院神经内科,河南新乡 453000

丁苯酞 替格瑞洛 缺血性脑血管病 心理状态 认知功能

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(1)
  • 14